Formulation of vaccines containing CpG oligonucleotides and alum

This publication has 17 references indexed in Scilit:

• Enhancement of functional antibody responses to AMA1-C1/Alhydrogel®, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide
  Vaccine, 2006
• Use of CpG oligodeoxynucleotides as immune adjuvants
  Immunological Reviews, 2004
• Biochemical and Immunological Characterization of Bacterially Expressed and RefoldedPlasmodium falciparum42-Kilodalton C-Terminal Merozoite Surface Protein 1
  Infection and Immunity, 2003
• CpG-A-Induced Monocyte IFN-γ-Inducible Protein-10 Production Is Regulated by Plasmacytoid Dendritic Cell-Derived IFN-α
  The Journal of Immunology, 2003
• Effect of the Degree of Phosphate Substitution in Aluminum Hydroxide Adjuvant on the Adsorption of Phosphorylated Proteins
  Pharmaceutical Development and Technology, 2003
• Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites
  Vaccine, 2002
• In Vitro Studies with RecombinantPlasmodium falciparumApical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response
  Infection and Immunity, 2002
• Large-Scale Purification and Characterization of Malaria Vaccine Candidate Antigen Pvs25H for Use in Clinical Trials
  Protein Expression and Purification, 2002
• Transmission-Blocking Vaccines
  2002
• Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo
  The Journal of Immunology, 2000